Navigation Links
Bristol-Myers Squibb to Announce Results for the Fourth Quarter and Full Year of 2007 on January 31
Date:1/16/2008

NEW YORK, Jan. 16 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY) will announce results for the fourth quarter and full year of 2007 on Thursday, January 31. During a 10 a.m. (ET) conference call on Jan. 31, company executives will review financial information and will address inquiries from investors and analysts.

Investors and the general public are invited to listen to a live webcast of the call at http://www.bms.com/ir or by dialing 913-312-0980. Materials related to the call will be available at the same website prior to the conference call. A replay of the call will be available beginning at 2 p.m. (ET) on January 31 through midnight (ET) on February 14. The replay will be available through http://www.bms.com/ir or by dialing 402-280-9013 (access code 6761149).

Bristol-Myers Squibb is a global biopharmaceutical and related health care products company whose mission is to extend and enhance human life.


'/>"/>
SOURCE Bristol-Myers Squibb Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Exelixis Submits XL139 Diligence Report to Bristol-Myers Squibb
2. EDS Awarded $715 Million Contract for Bristol-Myers Squibb Information Services
3. Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community
4. Bristol-Myers Squibb and Pierre Fabre Provide Update On Vinflunine Development Status
5. Aureus Pharma Announces Renewal and Expansion of Licensing Agreement With Bristol-Myers Squibb for its AurSCOPE Knowledge Databases
6. Bristol-Myers Squibb to Acquire Adnexus Therapeutics
7. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
8. GeneGo Enters Multi-Year Agreement With Bristol Myers Squibb for Access to GeneGo Software Suite and Databases
9. RSB Spine, LLC Announces First Implantation of the InterPlate(TM) L for the Lumbar Spine
10. Stereotaxis Announces FDA Approval of Its Partnered Magnetic Irrigated Catheter
11. Healthcare Technologies Ltd. (NASDAQ: HCTL) Announces Extension of Letters of Intent to Acquire Majority Interest in Two Ethanol Plants
Post Your Comments:
*Name:
*Comment:
*Email: